David M. Treiman, M.D. Publications

Biosketch > David Treiman, MD

Journal Articles

1. Levine S, Treiman DM: Differential plasma corticosterone response to stress in four inbred strains of mice. Endocrinology, 75:142 144, 1964.

2. Treiman DM, Levine S: Plasma corticosteroid response to stress in four species of wild mice. Endocrinology, 84:676 680, 1969.

3. Treiman DM, Faulkner D, Levine S: Interaction of genotype and environment as determinants of corticosteroid response to stress. Developmental Psychobiology, 3:131 140, 1970.

4. Tourian A, Treiman DM, Carr JS: Developmental biology of hepatic phenylalanine hydroxylase activity in foetal and neonatal rats synchronized as to conception. Biochimica et Biophysica Acta, 279:484 490, 1972.

5. Treiman DM, Tourian A: Phenylalanine hydroxylase in dilute lethal mice. Biochimica et Biophysica Acta, 313:163 169, 1973.

6. Hulanika MD, Kredich NM, Treiman DM: Structural gene for O acetylserine sulfhydralase-A in salmonella typhimurium. Identity with the trzA locus. Journal of Biological Chemistry, 249:867 872, 1974.

7. Delgado Escueta AV, Enrile-Bacsal F, Treiman DM: Complex partial seizures on the closed-circuit television and EEG: A study of 691 attacks in 79 patients. Annals of Neurology, 11:292 300, 1982.

8. Cummings JL, Syndulko K, Goldberg Z, Treiman DM: Palinopsia reconsidered. Neurology, 32:444-447, 1982.

9. Delgado Escueta AV, Wasterlain C, Treiman DM, Porter RJ: Current concepts in neurology: Management of status epilepticus. New England Journal of Medicine, 306:1337 1340, 1982.

10. Spilker B, Wilder BJ, Bruni J, Mattson R, Masland R, Resor S, Wannamaker B, Maddox R, Treiman DM et al: A multicenter study of the efficacy and safety of cinromide in patients with partial seizures. Current Therapy Research, 34:7-14, 1983.

11. Delgado Escueta AV, Treiman DM, Walsh GO: Medical progress: The treatable epilepsies. New England Journal of Medicine, 308:1508 1514, 308:1576 1584, 1983.

12. Mattson RH, Cramer JA, Delgado Escueta AV, Smith DB, Collins JF, and the VA Epilepsy Cooperative Study Group: Treiman DM, et al: A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults. Neurology, 33(Suppl.1): 14-25, 1983.

13. Cramer JA, Smith DB, Mattson RH, Delgado-Escueta AV, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: A method of quantification for the evaluation of antiepileptic drug therapy. Neurology, 33 (Suppl.1):26 37, 1983.

14. Mattson RH, Cramer JA, Collins JF, Smith DB, Brown TR, Delgado-Escueta AV, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Rosenthal NP, Mayersdorf A: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. VA Cooperative Study #118. New England Journal of Medicine, 313:145-151, 1985.

15. Treiman DM, Wilensky AJ, Ben Menachem E, Ojemann L, Yerby M, Barber KO, McCormick K, Cereghino JJ, White BG, Swisher K: Efficacy of nafimidone in the treatment of intractable partial seizures: Report of a two center pilot study. Epilepsia, 26:607 611, 1985.

16. Smith DB, Craft BR, Collins JF, Mattson RH, Cramer JA, and the VA Epilepsy Cooperative Study Group #118: Treiman DM et al: Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia, 27:760 768, 1986.

17. Treiman DM: Epilepsy and violence: Medical and legal issues. Epilepsia, 27(Suppl. 2):S77 S104, 1986.

18. Homan RW, Miller B, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Causes of treatment failure with antiepileptic drugs vary over time. Neurology, 37:1620 1623, 1987.

19. Treiman DM, Gunawan S: Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. Clinical Pharmacokinetics, 12:433 439, 1987.

20. Gunawan S, Treiman DM: High performance liquid chromatography determination of nafimidone and its major metabolite nafimidone alcohol in human plasma and urine. Journal of Chromatography, 414:389 398, 1987.

21. Treiman DM, Ben-Menachem E: Inhibition of carbamazepine and phenytoin metabolism by nafimidone, a new antiepileptic drug. Epilepsia, 28:699 712, 1987.

22. Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachem E, Napoliello MJ, Sherry KM, Szabo GK: Vigabatrin for refractory complex partial seizures: Multicenter single blind study with long term follow up. Neurology, 37:184 189, 1987.

23. Treiman DM: Efficacy and safety of antiepileptic drugs: A review of controlled trials. Epilepsia, 28(Suppl.3):S1 S8, 1987.

24. Smith DB, Mattson RH, Cramer JA, Collins JF, Novelly RA, Craft BR, and the VA Epilepsy Cooperative Study Group: Treiman DM, et al: Results of a Nationwide Veterans Administration Cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia, 28(Suppl.3):S50 S58, 1987.

25. Chelberg RH, Gunawan S, Treiman DM: Simultaneous high performance liquid chromatography determination of carbamazepine and its principal metabolites in human plasma and urine. Therapeutic Drug Monitoring, 10:188-193, 1988.

26. Gunawan S, Treiman DM: Determination of lorazepam in plasma of patients during status epilepticus by high performance liquid chromatography. Therapeutic Drug Monitoring, 10:172-176, 1988.

27. Walton NY, Treiman DM: Experimental secondarily generalized convulsive status epilepticus induced by D,L homocysteine thiolactone. Epilepsy Research, 2:79-86, 1988.

28. Cramer JA, Collins JF, Mattson RH, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Can categorization of patient background problems be used to determine early termination in a clinical trial? Controlled Clinical Trials, 9:47 63, 1988.

29. Treiman DM: Clinical benefits of vigabatrin. British Journal of Clinical Practice, 421 (Suppl.6):24-29, 1988.

30. Walton NY, Treiman DM: Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Experimental Neurology, 101:267-275, 1988.

31. Mattson RH, Cramer JA, Collins JF, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Aspects of compliance in epilepsy: Taking drugs and keeping appointments. Epilepsy Research, 2(Suppl.1):111-118, 1988.

32. Kapetanovic IM, Torchin DC, Kupferberg HJ, Treiman DM, DeGiorgio CM, Barber K, Norton L, Lau M, Whitley L, Cereghino JJ: Pharmacokinetic profile of flunarizine after single and multiple dosing in epileptic patients receiving comedication. Epilepsia, 29:770-774, 1988. 33. Ben Menachem E, Treiman DM: Effect of gamma vinyl GABA on interictal spikes and sharp waves in patients with intractable complex partial seizures. Epilepsia, 30:79-83, 1989.

34. Mattson RH, Cramer JA, McCutchen CB, and the VA Cooperative Study Group: Treiman DM et al: Barbiturate-related connective tissue disorders. Archives of Internal Medicine, 149:911-914, 1989.

35. Mikati MA, Browne TR, Collins JF, and the VA Epilepsy Cooperative Study #118 Group: Treiman DM et al: Time course of carbamazepine autoinduction. Neurology, 39:592-594, 1989.

36. Walton NY, Treiman DM: Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Research, 4:216-221, 1989.

37. Treiman DM: Gamma vinyl GABA: Current role in the management of drug-resistant epilepsy. Epilepsia, 30(Suppl.3): S31-S35, 1989.

38. Treiman DM: Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia, 30(Suppl.2):S4-S10, 1989.

39. Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachem E, Miketa RM, Sherry KM, Szabo GK: A multicenter study of vigabatrin for drug-resistant epilepsy. British Journal of Clinical Pharmacology, 27:95S-100, 1989.

40. Treiman DM, Walton NY, Kendrick C: A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Research, 5:49-60, 1990.

41. Gunawan S, Walton NY, Treiman DM: HPLC determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanate. Journal of Chromatography, 503:177-187, 1990.

42. Walton NY, Treiman DM: Efficacy of ACC-9653 (a phenytoin prodrug) in experimental status epilepticus in the rat. Epilepsy Research, 5:165-168, 1990.

43. Walton NY, Gunawan S, Treiman DM: Brain amino acid concentration during status epilepticus induced by lithium and pilocarpine. Experimental Neurology, 108:61-70, 1990.

44. Walton NY, Treiman DM: Lorazepam treatment of experimental status epilepticus in the rat: Relevance to clinical practice. Neurology, 40:990-994, 1990.

45. Treiman DM: The role of benzodiazepines in the management of status epilepticus. Neurology, 5(Suppl.2):32-42, 1990.

46. Gunawan S, Walton NY, Treiman DM: Analysis of lorazepam in rat brain using liquid/liquid and solid-phase extraction in combination with HPLC. Biomedical Chromatography, 4:168-170, 1990.

47. Nuwer MR, Browne TR, Dodson EW, Dreifuss FE, Engel J, Leppik IE, Mattson RH, Penry JK, Treiman DM, Wilder BJ: Generic substitutions for antiepileptic drugs. Neurology, 40:1647-1651, 1990.

48. Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachem E, McBride RG, Sherry KM: Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: An update. Neurology, 41:363-364, 1991.

49. Walton NY, Treiman DM: Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res, 553:97-104, 1991.

50. Pledger GW, Treiman DM: Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration. Controlled Clinical Trials, 12:768-779, 1991.

51. Schumacher GE, Barr JT, Browne TR, Collins JF, and the Veterans Administration Epilepsy Cooperative Study Group Test: Treiman DM, et al. Test performance characteristics of the serum phenytoin concentration (SPC): the relationship between SPC and patient response., Therapeutic Drug Monitoring 13:318-324, 1991.

52. Walton NY, Treiman DM: Valproic acid in experimental status epilepticus. Epilepsy Research. 12:199-205, 1992.

53. Mattson RH, Cramer JA, Collins JF, and the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group: Treiman DM, et al: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. New England Journal of Medicine. 327:765-771, 1992.

54. DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM: Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia, 33:23-27, 1992.

55. Treiman DM: Generalized convulsive status epilepticus in the adult. Epilepsia, 34(Suppl. 1):S2-S11, 1993.

56. The Professional Advisory Board of the Epilepsy Foundation of America. Writing Committee Members: Treiman DM, et al: The treatment of convulsive status epilepticus: Recommendations of the Epilepsy Foundation of America. JAMA, 270 (No.7): 854-859, 1993.

57. Treiman DM: Current treatment strategies in selected situations. Epilepsia, 34(Suppl 5): S17-S23, 1993.

58. Treiman DM, Pledger GW, DeGiorgio C, Tsay J-Y and Cereghino JJ: Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients. Epilepsia, 34(5):944-953, 1993.

59. US Gabapentin Study Group No. 5: Treiman DM, et al: Gabapentin as add-on therapy in refractory partial epilepsy: A Double-Blind, Placebo-Controlled, Parallel-Group Study. Neurology, 43:2292-2297, 1993.

60. Walton NY, Kang J, Treiman DM: An inexpensive method for control of methylmethacrylate fumes in the laboratory. Contemporary Topics in Laboratory Animal Science, 33:62-64, 1994.

61. Handforth A, Treiman DM: Effect of an adenosine antagonist and an adenosine agonist on status entry and severity in a model of limbic status epilepticus. Epilepsy Research, 18:29-42, 1994.

62. US Gabapentin Study Group: Treiman DM et al: The long term safety and efficacy of gabapentin as add-on therapy in drug resistant partial epilepsy. Epilepsy Research, 8:67-73, 1994.

63. Handforth A, Finch DM, Peters R, Tan AM, Treiman DM: Interictal spiking increases 2-deoxy[14C]glucose uptake and c-fos-like reactivity. Annals of Neurology, 35:724-731, 1994.

64. Privitera M, Treiman DM, Pledger GW, Sahlroot JT, Handforth A, Linde MS, France CR, Cereghino JJ, McCutchen CB, Wood JH, McDonnell C: Dezinamide for partial seizures: Results of an n-of-1 trial. Neurology, 44:1453-1458, 1994.

65. Handforth A, Treiman DM: A new, non-pharmacologic model of convulsive status epilepticus induced by electrical stimulation: behavioral/electroencephalographic observations and response to phenytoin and phenobarbital. Epilepsy Research, 19:15-25, 1994.

66. Pledger GW, Sackellares JC, Treiman DM, Pellock JM, Wright FS, Mikati M, Sahlroot JT, Tsay JY, Drake ME, Olson L, Handforth CA, Garnett WR, Schachter S, Kupferberg HJ, Ashworth MR, McCormick C, Leiderman D, Kapetanovic IM, Driscoll S, O'Hara K, Torchin CD, Gentile J, Kay A, Cereghino JJ: Flunarizine for treatment of partial seizures: Results of a concentration-controlled trial. Neurology, 44:1830-1836, 1994.

67. Handforth A, Treiman DM: Efficacy and tolerance of long-term, high-dose gabapentin: Additional observations. Epilepsia, 35:1032-1037, 1994.

68. Handforth A, Cheng J, Mandelkern MA, Treiman DM: Markedly increased metabolism of mesial temporal lobe in a case with PLEDS: Further evidence that PLEDS are a manifestation of partial status epilepticus, Epilepsia, 35:876-881, 1994. Reply to letter, 36:214-215, 1995.

69. Walton NY, Gunawan S, Treiman DM: Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine. Epilepsy Research, 19:237-244, 1994.

70. Walton NY, Rubinstein BK, Treiman DM: Cardiac hypertrophy secondary to status epilepticus in rats. Epilepsy Research, 20:121-124, 1995.

71. Handforth A, Treiman DM: Functional mapping of the early stages of status epilepticus: A 14C-2-deoxyglucose study in the lithium-pilocarpine model in rat. Neuroscience, 64:1057-1073, 1995.

72. Handforth A, Treiman DM: Functional mapping of the late stages of status epilepticus in the lithium-pilocarpine model in rat: A 14C-2-deoxyglucose Study. Neuroscience, 64:1075-1089, 1995.

73. Treiman DM: Electroclinical features of status epilepticus. Journal of Clinical Neurophysiology, 12(4):343-362, 1995.

74. Handforth A, Mai T, Treiman DM: Rising dose study of safety and tolerance of flunarizine. European Journal of Clinical Pharmacology, 49:91-94, 1995.

75. Walton NY, Jaing Q, Hyun BS, Treiman DM: Lamotrigine versus phenytoin for treatment of status epilepticus: Comparison in an experimental model. Epilepsy Research, 24:19-28, 1966.

76. Mattson RH, Cramer JA, Collins JF and the Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group: Treiman DM et al.: Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology, 47:68-76, 1996.

77. Jaing Q, Walton NY, Gunawan S, Treiman DM: High-performance liquid chromatographic determination of midazolam in rat brain. Journal of Chromatography B: Biomedical Applications, 683:276-280,1996.

78. Treiman DM: Neuron specific enolase and status epilepticus-induced neuronal injury (editorial). Epilepsia, 37:595-597, 1996.

79. Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Effect of valproate on cognitive functioning. Comparison with carbamazepine. Archives of Neurology, 53:1008 16, 1996.

80. Nagy AK, Walton NY, Treiman DM: Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine. Molecular and Chemical Neuropathology, 31:135-147, 1997. 81. Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM: Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions. Brain Research, 765:228-237, 1997.

82. Holschneider DP, Leuchter AF, Scremin OU, Treiman DM, Walton NY: Effects of cholinergic deafferentation and NGF on brain electrical coherence. Brain Research Bulletin, 45:531-541, 1998.

83. Prevey ML, Delaney RC, Cramer JA, Mattson RH, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Complex partial and secondarily generalized seizure patients: cognitive functioning prior to treatment with antiepileptic medication. Epilepsy Research. 30:1 9, 1998.

84. Treiman DM, Walton NY, Meyers, PD, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB, Yagnik P, Jones JC, Barry E, Boggs JG, Kanner AM: A comparison of four treatments for generalized convulsive status epilepticus. New England Journal of Medicine, 339:792-798, 1998.

85. Walton NY, Nagy AK, Treiman DM. Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine. Journal of Molecular Neuroscience, 11:233-242, 1998.

86. Walton NY, Uthman BM, El Yafi K, Kim JM, Treiman DM: Phenytoin penetration into brain after administration of phenytoin or fosphenytoin. Epilepsia 40(2):153-156, 1999.

87. Shinnar S, Berg AT, Treiman DM, Hauser WA, Hesdorffer DC, Sackellares JC, Leppik I, Sillanpaa M, Sommerville KW. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia, 42:372-379, 2001.

88. French JA, Kugler AR, Robbins JL, Knapp LE, Garofallo EA and the Pregabalin Investigators: Treiman DM, et al.: Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60:1631-1637, 2003.

89. Good LB, Sabesan S, Iasemidis LD, Tsakalis K, Treiman DM: Brain dynamical disentrainment by anti-epileptic drugs in rat and human status epilepticus. Conference Proceedings Institute of Electrical and Elecronics Engineers Engineering in Medicine and Biology Society. 2004;1:176-9.

90. Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, Delorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, Kaplan P, Koutroumanidis M, O’regan M, Plouin P, Sander J, Scott R, Shorvon S, Treiman D, Wasterlain C, Wieshmann U: Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports. Epileptic Disorders. 2005 Sep;7(3):253-96.

91. Good L, Sabesan S, Iasemidis L, Treiman D: Real-Time Control of Epileptic Seizures, International Federation for Medical and Biological Engineering Proceedings. 11(1), 2005.

92. Iasemidis L, Sabesan S, Good L, Tsakalis K, Treiman D: Prediction and Control of Epileptic Seizures: the basis for brain pacemakers in epilepsy, International Federation for Medical and Biological Engineering Proceedings. 11(1), 2005.

93. Sabesan S, Good L, Iasemidis L, Tsakalis K, Treiman D: Epileptic brain dynamics and information flow. International Federation for Medical and Biological Engineering Proceedings. 11(1), 2005.

94. Bristol RE, Gore P, Treiman D, Smith KA: Resoltion of status epilepticus after subdural grid recording and multiple subpial transactions. Barrow Quarterly. 22(2), 2006.

95. Treiman DM, Walker MC: Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus, Epilepsy Res. 68 Suppl 1: S77-82, 2006.

96. Treiman DM, Treatment of convulsive status epilepticus. International Review of Neurobiology. 81:273-85, 2007.

97. Little AS, Ng YT, Kerrigan JF, Treiman DM, Fram E, Rekate HL. Anterior motor strip displacement in a boy with right frontal gray matter heterotopia undergoing epilepsy surgery. Epilepsy Behav.11:241-246, 2007.

98. Chung SS, Wang NC, Treiman DM. Comparative efficacy and safety of antiepileptic drugs for the treatment of status epilepticus. Journal of Pharmacy Practice. 20:137-146, 2007.

99. Little AS, Smith KA, Lekovic GP, Treiman DM, Porter RW, Shetter AG. Functional cortical mapping using subdural grid electrodes in patients with low-grade gliomas presenting with seizure. Barrow Quarterly, 24(1):4-8, 2008.

100. Treiman DM. Importance of early recognition and treatment of eneralized convulsive status epilepticus. Lancet Neurol. 7(8):667-8, 2008.

101. Gerber PA, Chapman KE, Chung SS, Drees C, Maganti RK, Ng YT, Treiman DM, Little AS, Kerrigan JF. Interobserver agreement in the interpretation of EEG patterns in critically ill adults. Journal of Clinical Neurophysiology. 25:241-9, 2008.

102. Wheless JW, Treiman DM. The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus. Epilepsia. 49(Suppl 9):74-8, 2008.

103. Wang NC, Good LB, Marsh ST, Treiman DM. EEG stages if experimental status epilepticus predict treatment response. Epilepsia, 50(4):949-52, 2009.

104. Sabesan S, Good LB, Tsakalis K, Spanias A, Treiman DM, Iasemidis LD. Information flow and application to epileptogenic focus localization from intracranial EEG. IEEE Transaction on Neural Systems and Rehabilitation Engineering, 17(3):244-253, 2009.

105. Good LB, Sabesan S, Marsh ST, Tsakalis K, Treiman DM, Iasemidis L. Control of Synchronization of brain dynamics leads to control of epileptic seizures in rodents. International Journal of Neural Systems, 19(3):173-96, 2009.

106. Tu J-l, Zhao C-b, Vollmer T, Coons S, Lin HJ, Marsh S, Treiman DM, Shi J. APOE 4 polymorphism results in early cognitive deficits in an EAE model. Biochemical and Biophysical Research Communications, 384(4):466-70, 2009.

107. Little AS, Smith KA, Kirlin K, Baxter LC, Chung S, Maganti R, Treiman DM. Modifications to the subtemporal selective amygdalohippocampectomy using a minimal access technique: seizure and neuropsychological outcomes. Journal of Neurosurgery, 111(6):1263-1274, 2009.

108. Fessler AJ, Treiman DM. Epilepsy and Aggression – Proceed with Caution. Neurology, 73(21):1720-1721, 2009.

109. Grill M, Treiman DM, Maganti R. Status epilepticus associated with subtentorial posterior fossa lesions. Archives of Neurology, 66(12):1500-1554, 2009.

110. Crepeau AZ, Treiman DM. Levetiracetam: a comprehensive review. Expert Review of Neurotherapeutics, 10(2):159-171, 2010.

111. Treiman DM. Management of refractory complex partial seizures: current state of the art. Neuropsychiatric Disease and Treatment, in press.

Chapters and Invited Articles

1. Levine S, Treiman DM: Determinants of individual differences in the steroid response to stress. In: E. Bajusz, ed. Physiology and Pathology of Adaption Mechanisms, pp. 171 184, Oxford: Pergamon Press, 1969.

2. Mahaley MS, Weber EL, Treiman DM: Unusual causes of unilateral enlargement of the optic canal. In: J. Lawton Smith, ed. Neuro Ophthalmology, pp. 61 72, Springfield: Charles C. Thomas, 1972.

3. Treiman DM, Delgado Escueta AV: Status epilepticus. In: R. Thompson and J.R. Green, eds. Critical Care of Neurologic and Neurosurgical Emergencies, pp. 53 99, New York: Raven Press, 1980.

4. Treiman DM, Delgado Escueta AV: How to evaluate and treat episodic loss of consciousness. Drug Therapy, 10:112 124, 1980.

5. Treiman DM: Seizure types and causes of epilepsy. Seminars in Neurology, 1:65 75, 1981.

6. Delgado Escueta AV, Treiman DM, Enrile-Bacsal F: Phenotypic variations of seizures in adolescents and adults. In: V.E. Anderson, J.K. Penry, W.A. Hauser and C.S. Sing, eds. Genetic Basis of the Epilepsies, pp. 9 81, New York: Raven Press, 1982.

7. Treiman DM, Delgado Escueta AV: Subclassification of complex partial seizures by CCTV/EEG analysis. In: H. Akimoto, H. Kazamatsuri, M. Seino, eds. Advances in Epileptology: XIIIth Epilepsy International Symposium, pp. 61 64, New York: Raven Press, 1982.

8. Treiman Tokunow J, Treiman DM: New media approaches for public awareness about epilepsy. In: H. Akimoto, H. Kazamatsuri, M. Seino, eds. Advances in Epileptology: XIIIth Epilepsy International Symposium, pp.467 470, New York: Raven Press, 1982.

9. de la Sota A, Herfindahl L, Lee J, Clark M, Treiman DM: "Circles of Decisions": A new epilepsy patient education program. In: H. Akimoto, H. Kazamatsuri, M. Seino, eds. Advances in Epileptology: XIIIth Epilepsy International Symposium, pp. 471 473, New York: Raven Press, 1982.

10. Treiman DM, Delgado Escueta AV: Complex partial status epilepticus. In: A.V. Delgado-Escueta, C.G. Wasterlain, D.M. Treiman and R.J. Porter, eds. Advances in Neurology, Vol. 34: Status Epilepticus, Mechanisms of Brain Damage and Treatment, pp. 69 81, New York: Raven Press, 1983.

11. Treiman DM: General principles of treatment: Responsive and intractable status epilepticus in adults. In: A.V. Delgado Escueta, C.G. Wasterlain, D.M. Treiman and R.J. Porter, eds. Advances in Neurology, Vol. 34: Status Epilepticus, Mechanisms of Brain Damage and Treatment, pp. 377 384, New York: Raven Press, 1983.

12. Delgado Escueta AV, Wasterlain C, Treiman DM, Porter RJ: Status epilepticus: Summary. In: A.V. Delgado- Escueta, C. Wasterlain, D.M. Treiman and R.J. Porter, eds. Advances in Neurology, Vol. 34: Status Epilepticus: Mechanisms of Brain Damage and Treatment, pp. 537 541, New York: Raven Press, 1983.

13. Treiman DM, Delgado Escueta AV: Violence and epilepsy: A critical review. In: T.A. Pedley and B.S. Meldrum, eds. Recent Advances in Epilepsy, Vol. 1, pp. 179 209, London: Churchill Livingstone, 1983.

14. Delgado Escueta AV, Treiman DM: The emergency treatment of status epilepticus. In: R.T. Johnson, ed. Current Therapy in Neurological Disease, pp. 51 60, Philadelphia: BC Decker, Inc., 1984.

15. Buhles W, Wallach M, Chaplin M, Treiman DM: Nafimidone. In: B.S. Meldrum and R.J. Porter eds. New Anticonvulsant Drug Treatment, pp. 203 214, London: John Libby, 1986.

16. Mattson RH, Cramer JA, Collins JF, and the VA Epilepsy Cooperative Study Group: Treiman DM et al: Early tolerance to antiepileptic drug side effects: A controlled trial of 247 patients. In: H.H. Frey, W. Frosher, W.P. Koella and H. Meinardi, eds. Tolerance to Beneficial and Adverse Effects of Antiepileptic Drugs, pp. 149 156, New York: Raven Press, 1986.

17. Delgado-Escueta AV, Treiman DM: Focal status epilepticus: Modern concepts. In: H. Luders and R.P. Lesser, eds. Epilepsy: Electroclinical Syndromes, pp. 347-39, Berlin: Springer Verlag, 1987.

18. Treiman DM: Status epilepticus. In: R.T. Johnson, ed. Current Therapy in Neurologic Disease, 2nd edition, pp. 38 42, Philadelphia: B.C. Decker Inc., 1987.

19. Treiman DM, Delgado-Escueta AV: Complex partial status epilepticus. The Japanese Journal of Psychiatry and Neurology, 42:427-440, 1988.

20. Treiman DM: Genetics of the partial epilepsies. In: G. Beck-Mannagetta, V.E. Anderson, H. Doose, and D. Janz, eds. Genetics of the Epilepsies, pp. 73-82, Berlin: Springer Verlag, 1989.

21. Treiman DM: Recommendations for antiepileptic drug-interaction studies before controlled clinical trials. In: W.H. Pitlick, ed. Antiepileptic Drug Interactions, pp 89-113, New York: Demos Publications, 1989.

22. Treiman DM: New approaches to the development of antiepileptic drugs. In: P. Riekkinen, ed. New Approaches to the Evaluation and Treatment of Epilepsy, Helsinki, 1990.

23. Treiman DM: Epilepsy and aggression. In: D.B. Smith, ed. Epilepsy: Current Approaches to Diagnosis and Treatment, pp. 211-226, New York: Raven Press, 1990.

24. Treiman DM: Special treatment problems in adults. In: D.B. Smith, ed. Epilepsy: Current Approaches to Diagnosis and Treatment, pp. 155-172, New York: Raven Press, 1990.

25. Treiman DM: Treatment of alcohol withdrawal seizures with benzodiazepines. In: R.J. Porter, R.H. Mattson, J.A. Cramer, eds. Alcohol and Seizures, pp 283-289, New York: F.A. Davis, 1990.

26. Treiman DM: Status epilepticus. Current Opinion in Neurology and Neurosurgery, 3:277-283, 1990.

27. Therapeutics and Technology Subcommittee of the American Academy of Neurology, Treiman DM et al: Assessment: generic substitution for antiepileptic medication. Neurology, 40:1641-1643, 1990.

28. Treiman DM: Psychobiology of ictal aggression. In: D.B. Smith, D.M. Treiman, M.R. Trimble, eds. Advances in Neurology, Vol 55: Neurobehavioral Problems in Epilepsy, pp 341-356, New York: Raven Press, 1991.

29. Treiman DM, Walton NY, Gunawan S: Brain amino acid concentrations during specific stages of status epilepticus in the rat. In: G. Avanzini, J. Engel Jr., R.G. Fariello, U. Heinemann, eds. Neurotransmitters in Epilepsy , pp 283-295, New York: Elsevier. [Epilepsy Res (Suppl 8)], 1992.

30. Treiman DM: Status epilepticus. In: S.R. Resor, Jr., H. Kutt eds. The Medical Treatment of Epilepsy, pp 183-193, New York: Marcel Dekker, 1992.

31. Porter RJ, Schmidt D, Treiman DM, Nadi NS: Pharmacologic approaches to the treatment of focal seizures: past, present and future In: P. Chauvel, A.V. Delgado-Escueta, E. Halgren, J. Bancaud, eds. Advances in Neurology, Vol 57: Frontal Lobe Seizures and Epilepsies, pp. 607-634, New York: Raven Press, 1992.

32. Treiman DM: Status epilepticus. In: J. Laidlaw, A. Richens, D. Chadwick, eds. Textbook of Epilepsy, 4th Edition, pp 205-220, London: Edinburgh, Churchill/Livingstone, 1993.

33. Treiman DM: Epilepsy and the law. In: J. Laidlaw, A. Richens, D. Chadwick, eds. Textbook of Epilepsy, 4th Edition, pp 645-659, London: Edinburgh, Churchill/Livingstone, 1993.

34. Treiman LJ, Treiman DM: Genetic aspects of epilepsy. In: E. Wyllie, ed. The Treatment of Epilepsy: Principles and Practice, pp 145-156, Philadelphia: Lea & Febriger, 1993.

35. Treiman DM: Epileptic emergencies and status epilepticus. In: J.C. Grotta, ed. Management of the Acutely Ill Neurological Patient. pp. 111-121, Churchill Livingstone, 1993.

36. Treiman DM: Status epilepticus. In: R.T. Johnson, M.D. and J.W. Griffin, ed. Current Therapy in Neurological Diseases, 4th Edition, pp 52-55, Mosby-Year Book, 1993.

37. Treiman LJ, Treiman DM: New developments in the genetics of epilepsy. AES News, 2:4-6, April, 1993.

38. Treiman DM: Study population selection. In: J.A. French, M.A. Dichter, I.E. Leppik, eds. New Antiepileptic Drug Development: Preclinical and Clinical Aspects, pp 125-135, Amsterdam: Elsevier [Epilepsy Research, (Suppl. 10)], 1993.

39. Treiman DM: Ethical considerations. In: J.A. French, M.A. Dichter, I.E. Leppik, eds. New Antiepileptic Drug Development: Preclinical and Clinical Aspects, pp 137-148, Amsterdam: Elsevier [Epilepsy Research, (Suppl. 10)], 1993.

40. Treiman DM et al: Southern Clinical Neurological Society Round Table. Current Antiepileptic Drugs: Efficacy and Therapeutics. Gainesville, FL, Research Foundation of Florida, 1993.

41. Treiman DM: Generalized convulsive, nonconvulsive and focal status epilepticus. In: E. Feldmann, ed. Current Diagnosis in Neurology, pp 11-18, Mosby-Year Book, 1994.

42. Treiman DM: Aggressive behavior and violence in epilepsy: Guidelines for expert testimony. In: R. Rosner, ed. Principles and Practice of Forensic Psychiatry: A Comprehensive Textbook, pp 451-460, New York, Chapman and Hall, 1994.

43. Treiman DM: Status epilepticus. Current Opinion in Critical Care, 1:104-110, 1995. 44. Treiman DM: Treatment strategies. In: L.J. Wilmore, ed., Monograph: Generalized Tonic-Clonic Seizures: Identification, Classification and Treatment, pp 54-69, Deerfield, IL, Discovery International, 1995. 45. Treiman DM, Woodbury, DM: Phenytoin: absorption, distribution and excretion. In: R.H. Levy, R.H. Mattson, B.S. Meldrum, eds., Antiepileptic Drugs, 4th Edition, pp 301-314, New York, Raven Press Ltd., 1995.

46. Homan RW, Treiman DM: Lorazepam. In: R.H. Levy, R.H. Mattson, B.S. Meldrum, eds., Antiepileptic Drugs, 4th Edition, pp 779-790, New York, Raven Press, Ltd., 1995.

47. Treiman DM: Generalized convulsive status epilepticus. In: S. Gilman, S. Waxman, G. Goldstein, eds., Neurobase, San Diego, Arbor Publications, 1995. Updated February, 1997.

48. Treiman DM, Meyers PD, Walton NY and the DVA Status Epilepticus Study Group: Status epilepticus in the elderly: nosology and therapy. In: A.J. Rowan, R.E. Ramsay, eds. Seizures and Epilepsy in the Elderly, pp 207-215, Boston, Butterworth/Heine¬mann, 1966.

49. Walton NY, Treiman DM: Rational polytherapy in the treatment of status epilepticus. In: I.E. Leppik, R. Homan, eds. Rational Polypharmacy, pp 123-139, New York, Elsevier [Epilepsy Research, (Suppl. 11)], 1996.

50. Treiman DM: Status epilepticus. In: M.J. Brodie, D.M. Treiman, eds., Modern Management of Epilepsy. Baillière's Clinical Neurology. pp 821-839, (Vol. 5, No. 4), Philadelphia, Baillière Tindal, 1996.

51. Treiman DM: Perspectives for development of epilepsy treatment in the 21st century. In: T. Salonen, J. Sivenius, J. Sirviö, P. Riekkinen Jr, Anja Salminen, eds,. 20 Years of Brain Research in Kuopio, 20th Anniversary of the Department of Neuroscience and Neurology, pp 76-80, Kuopio, Finland, University of Kuopio, Department of Neuroscience and Neurology, 1996.

52. Treiman LJ, Treiman DM: Genetic aspects of epilepsy. In: E. Wyllie, ed. The Treatment of Epilepsy: Principles and Practice, 2nd edition, pp 151-164, Baltimore, Williams & Wilkins, 1997.

53. Treiman DM: Posttraumatic Epilepsy. In: S. Gilman, S. Waxman, G. Goldstein, eds., Neurobase, San Diego, Arbor Publications, 1997.

54. Treiman DM: Status Epilepticus. In: T. Yamauchi, K. Yagi, eds. Epilepsy Interview Series, Osaka, Japan, Adis International Ltd, 1997.

55. Treiman DM, Heinemann U.: Experimental Models of Status Epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook. Philadelphia, PA, Lippincott-Raven Publishers, pp 443-455, 1997.

56. Treiman DM: Generalized convulsive status epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook. Philadelphia, PA, Lippincott-Raven Publishers, pp 669-680, 1997.

57. Treiman DM: Treatment of status epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook. Philadelphia, PA, Lippincott-Raven Publishers, pp 1317-1323, 1997.

58. Kim J-M, Treiman DM: New developments in the treatment of seizures and status epilepticus: Current Opinion in Critical Care, 3:101-109, 1997.

59. Treiman DM: Clinical trials for status epilepticus. In: M.A. Dichter, J.A French, I.E Leppik, eds. Advances in Neurology, Vol 76: Antiepileptic Drug Development, pp 173-178. Philadelphia: Lippincott-Raven Publishers, 1998.

60. Treiman DM: Status epilepticus: recent developments, current management, future directions. In: T. Salonen, A. Yinen, eds. 100 Year of Epilepsy Care and Research in Kuopio, pp 46-47. Kuopio, Finland: University of Kuopio Publishers, 1998.

61. Treiman LJ, Treiman DM: Genetic epilepsies B generalized. In: P. Kotagal, H. O. Lhuders, eds., The Epilepsies - Etiologies and Prevention, pp 543-549. San Diego, CA, Academic Press, 1998.

62. Treiman DM. Violence and the epilepsy defense. Neurologic Clinics, 17:245 55, 1999. 63. Treiman DM: Convulsive status epilepticus. Current Treatment Options in Neurology, 1:359-369, 1999.

64. Treiman DM: Effective treatment for status epilepticus. In: D. Schmidt and S.C. Schachter, eds., Epilepsy: Problem Solving In Clinical Practice, pp 253-266. London, Martin Dunitz Ltd., 2000.

65. Treiman DM: Neocortical status epilepticus. In: P. Williamson, A.M. Siegel, D.W. Roberts, V.M. Thandi, M.S. Gazzaniga, eds, Advances in Neurology, Volume 84, Neocortical Epilepsies), pp 243-251. Philadelphia, Lippincott Williams & Wilkins, 2000.

66. Treiman DM: Therapy of status epilepticus in adults and children. In: C. Elger, ed. Seizure Disorders. Current Opinion in Neurology, 14:203-210, 2001.

 67. Treiman LJ, Treiman DM: Genetic aspects of epilepsy. In: E. Wyllie, ed. The Treatment of Epilepsy: Principles and Practice, 3rd edition, pp 115-129. Philadelphia, Lippincott Williams & Wilkins, 2001.

68. Treiman DM: Status epilepticus. In: E. Wyllie, ed. The Treatment of Epilepsy: Principles and Practice, 3rd edition, pp 681-697. Philadelphia, Lippincott Williams & Wilkins, 2001.

69. Treiman DM: GABAergic mechanisms in epilepsy. Epilepsia, 42(Suppl 3):8-12, 2001.

70. Treiman DM: Will brain damage after status epilepticus be history in 2010? In T.P. Sutula, A. Pitkanen, eds. Do seizures cause brain damage? Progress in Brain Research, Vol. 135, pp 471-478, 2002.

71. Treiman DM: Violence and epilepsy: an approach to expert testimony. In: R. Rosner, ed. Pinciples and Practice of Forensic Psychiatry: A Comprehensive Textbook, 2nd edition, New York, Chapman and Hall, 2003.

72. Treiman DM: Status Epilepticus. In M.J. Aminoff, R.B. Darroff, eds. Encyclopedia of the Neurological Sciences, San Diego, Academic Press/Reed Elsevier, 2003.

73. Treiman DM: Generalized convulsive status epilepticus. In: C.L. Wasterlain, D.M. Treiman, eds. Status Epilepticus: Mechanisms and Management, pp 55-68. Boston, MIT Press, 2006.

74. Wasterlain CL, Treiman DM: Status epilepticus: the future. In: C.L. Wasterlain, D.M. Treiman, eds. Status Epilepticus: Mechanisms and Management, pp 621-622. Boston, MIT Press, 2006.

75. Avanzini G, Treiman DM, Engel J: Experimental models of partial seizures and status epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook, 2nd edition, pp 415-444. Philadelphia, Lippincott Williams & Wilkins, 2008.

76. Treiman DM: Generalized convulsive status epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook, 2nd edition, pp 665-676. Philadelphia, Lippincott Williams & Wilkins, 2008.

77. Alldredge BA, Treiman DM: Treatment of status epilepticus. In: J. Engel Jr, T.A. Pedley, eds., Epilepsy. A Comprehensive Textbook, 2nd edition, pp 1357-1364. Philadelphia, Lippincott Williams & Wilkins, 2008.

78. Iasemidis LD, Sabesan S, Good L, Chakravarthy N, Treiman D, Sirven J. A new look into epilepsy as a dynamical disease: seizure prediction, resetting and control. In: Schwartzkroin P, ed., Encyclopedia of Basic Epilepsy Research, Vol 3, pp 1295-1302. Oxford, Academic Press, 2009.

79. Treiman DM: Convulsive status epilepticus. In: J.W. Wheless, L.J. Willmore, R.A. Brumback, eds., Advanced Therapy in Epilepsy, pp 144-151. Shelton, CT, USA, People’s Medical Publishing House, 2009.

80. Treiman LJ, Treiman DM: Genetics and chromosomal disorders in epilepsy. In: J.W. Wheless, L.J. Willmore, R.A. Brumback, eds., Advanced Therapy in Epilepsy, pp 67-76. Shelton, CT, USA, People’s Medical Publishing House, 2009.

Books

1. Delgado Escueta AV, Wasterlain C, Treiman DM, Porter RJ, eds.: Advances in Neurology, Vol 34: Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York: Raven Press, 1983.

2. Treiman Tokunow J, Saunders J, Treiman DM: Guide to Films, Videotapes and Slides about Epilepsy. Washington: Epilepsy Foundation of America, 1985.

3. Smith DB, Treiman DM, Trimble MJ, eds: Advances in Neurology, Vol 55: Neurobehavioral Problems in Epilepsy. New York: Raven Press, 1991.

4. Brodie MJ, Treiman DM, eds., Modern Management of Epilepsy. Baillière's Clinical Neurology. International Practice and Research, Philadelphia: Baillière Tindal, 1996.

5. Treiman DM et al., Section editor: Phenomenology, Vol. 1 and Antiepileptic Drugs, Vol. 2 in J Engel Jr, TA Pedley, eds., Epilepsy, A Comprehensive Textbook. Philadelphia: Lippincott-Raven, 3 Vols, 1998.

6. Wasterlain CL Treiman DM, eds., Status Epilepticus: Mechanisms and Management. Boston: MIT Press, 2006.

David Treiman, MD | Epilepsy Team | Epilepsy Center